200 related articles for article (PubMed ID: 35987350)
21. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
[TBL] [Abstract][Full Text] [Related]
22. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
[TBL] [Abstract][Full Text] [Related]
23. Increased Infections and Delayed CD4
Khimani F; Ranspach P; Elmariah H; Kim J; Whiting J; Nishihori T; Locke FL; Perez Perez A; Dean E; Mishra A; Perez L; Lazaryan A; Jain MD; Nieder M; Liu H; Faramand R; Hansen D; Alsina M; Ochoa L; Davila M; Anasetti C; Pidala J; Bejanyan N
Transplant Cell Ther; 2021 Nov; 27(11):940-948. PubMed ID: 34329754
[TBL] [Abstract][Full Text] [Related]
24. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
[TBL] [Abstract][Full Text] [Related]
25. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
Gooptu M; Kim HT; Chen YB; Rybka W; Artz A; Boyer M; Johnston L; McGuirk J; Shea TC; Jagasia M; Shaughnessy PJ; Reynolds CG; Fields M; Alyea EP; Ho VT; Glavin F; Dipersio JF; Westervelt P; Ritz J; Soiffer RJ
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2216-2223. PubMed ID: 30006305
[TBL] [Abstract][Full Text] [Related]
26. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts.
Hale JE; Platt CD; Bonilla FA; Hay BN; Sullivan JL; Johnston AM; Pasternack MS; Hesterberg PE; Meissner HC; Cooper ER; Barmettler S; Farmer JR; Fisher D; Walter JE; Yang NJ; Sahai I; Eaton RB; DeMaria A; Notarangelo LD; Pai SY; Comeau AM
J Allergy Clin Immunol Pract; 2021 May; 9(5):2060-2067.e2. PubMed ID: 33607339
[TBL] [Abstract][Full Text] [Related]
27. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Castermans E; Hannon M; Dutrieux J; Humblet-Baron S; Seidel L; Cheynier R; Willems E; Gothot A; Vanbellinghen JF; Geenen V; Sandmaier BM; Storb R; Beguin Y; Baron F
Haematologica; 2011 Feb; 96(2):298-306. PubMed ID: 20934996
[TBL] [Abstract][Full Text] [Related]
28. Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Baron F; Storer B; Maris MB; Storek J; Piette F; Metcalf M; White K; Sandmaier BM; Maloney DG; Storb R; Boeckh M
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1176-87. PubMed ID: 17085311
[TBL] [Abstract][Full Text] [Related]
29. Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.
Okamoto H; Arii C; Shibata F; Toma T; Wada T; Inoue M; Tone Y; Kasahara Y; Koizumi S; Kamachi Y; Ishida Y; Inagaki J; Kato M; Morio T; Yachie A
Clin Exp Immunol; 2007 Jun; 148(3):450-60. PubMed ID: 17374134
[TBL] [Abstract][Full Text] [Related]
30. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
31. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
Front Immunol; 2019; 10():1997. PubMed ID: 31507601
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
33. Long term outcomes of severe combined immunodeficiency: therapy implications.
Heimall J; Cowan MJ
Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
[TBL] [Abstract][Full Text] [Related]
34. Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.
Bhattacharyya A; Hanafi LA; Sheih A; Golob JL; Srinivasan S; Boeckh MJ; Pergam SA; Mahmood S; Baker KK; Gooley TA; Milano F; Fredricks DN; Riddell SR; Turtle CJ
Biol Blood Marrow Transplant; 2018 Feb; 24(2):242-251. PubMed ID: 29024803
[TBL] [Abstract][Full Text] [Related]
35. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.
Borghans JA; Bredius RG; Hazenberg MD; Roelofs H; Jol-van der Zijde EC; Heidt J; Otto SA; Kuijpers TW; Fibbe WE; Vossen JM; Miedema F; van Tol MJ
Blood; 2006 Jul; 108(2):763-9. PubMed ID: 16822903
[TBL] [Abstract][Full Text] [Related]
36. Lymphopenia and Severe Combined Immunodeficiency (SCID) - Think Before You Ink.
Aluri J; Gupta MR; Dalvi A; Mhatre S; Kulkarni M; Desai M; Shah NK; Madkaikar MR
Indian J Pediatr; 2019 Jul; 86(7):584-589. PubMed ID: 30879237
[TBL] [Abstract][Full Text] [Related]
37. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
38. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
Bacchetta R; Bigler M; Touraine JL; Parkman R; Tovo PA; Abrams J; de Waal Malefyt R; de Vries JE; Roncarolo MG
J Exp Med; 1994 Feb; 179(2):493-502. PubMed ID: 7905018
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
Simonetta F; Pradier A; Bosshard C; Masouridi-Levrat S; Dantin C; Koutsi A; Tirefort Y; Roosnek E; Chalandon Y
Front Immunol; 2019; 10():1034. PubMed ID: 31156625
[TBL] [Abstract][Full Text] [Related]
40. Thymic Activity and T Cell Repertoire Recovery after Autologous Hematopoietic Stem Cell Transplantation Preceded by Myeloablative Radiotherapy or Chemotherapy.
Głowala-Kosińska M; Chwieduk A; Smagur A; Fidyk W; Najda J; Mitrus I; Giebel S
Biol Blood Marrow Transplant; 2016 May; 22(5):834-42. PubMed ID: 26797400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
